A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of the Safety, Tolerability and Population Pharmacokinetics of CMX001 in Post-Transplant Subjects With BK Virus Viruria.
Phase of Trial: Phase I/II
Latest Information Update: 12 Nov 2011
At a glance
- Drugs Brincidofovir (Primary)
- Indications Human polyomavirus infections
- Focus Adverse reactions
- 12 Nov 2011 Results were presented at a late-breaking session at the Annual Meeting of the American Society of Nephrology (ASN) Kidney Week 2011.
- 15 Mar 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 15 Mar 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.